Recently, genetic activation of Shh signaling in mouse hypothalamic astrocytes has been shown to increase sensitivity to blood glucose levels and to display a major role in counteracting metabolic defects associated with aging and obesity (Tirou et al. 2021). Here, SHH is linked to obesity disorder.